EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Bacterial peptidoglycan signalling in microglia: Activation by MDP via the NF-κB/MAPK pathway

Julia Spielbauer, Elliot J Glotfelty, Heela Sarlus, Robert A Harris, Rochellys Diaz Heijtz, Tobias E Karlsson

Brain, Behavior, and Immunity · 2024

DOI: 10.1016/j.bbi.2024.06.027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, Behavior, and Immunity, 2024. Verfasst von Julia Spielbauer und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, Karolinska Institutet, 171 77 Stockholm, Sweden. Electronic address: julia.spielbauer@ki.se. Hauptthemen laut MEDLINE: Acetylmuramyl-Alanyl-Isoglutamine, Microglia, Peptidoglycan, Signal Transduction. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bacterial peptidoglycan (PGN) fragments are commonly studied in the context of bacterial infections. However, PGN fragments recently gained recognition as signalling molecules from the commensal gut microbiota in the healthy host. Here we focus on the minimal bioactive PGN motif muramyl dipeptide (MDP), found in both Gram-positive and Gram-negative commensal bacteria, which signals through the Nod2 receptor. MDP from the gut microbiota translocates to the brain and is associated with changes in neurodevelopment and behaviour, yet there is limited knowledge about the underlying mechanisms. In this study we demonstrate that physiologically relevant doses of MDP induce rapid changes in microglial gene expression and lead to cytokine and chemokine secretion. In immortalised microglial (IMG) cells, C-C Motif Chemokine Ligand 5 (CCL5/RANTES) expression is acutely sensitive to the lowest physiologically prevalent dose (0.1 µg/ml) of MDP. As CCL5 plays an important role in memory formation and synaptic plasticity, microglial CCL5 might be the missing link in elucidating MDP-induced alterations in synaptic gene expression. We observed that a higher physiological dose of MDP elevates the expression of cytokines TNF-α and IL-1β, indicating a transition toward a pro-inflammatory phenotype in IMG cells, which was validated in primary microglial cultures. Furthermore, MDP induces the translocation of NF-κB subunit p65 into the nucleus, which is blocked by MAPK p38 inhibitor SB202190, suggesting that an interplay of both the NF-κB and MAPK pathways is responsible for the MDP-specific microglial phenotype. These findings underscore the significance of different MDP levels in shaping microglial function in the CNS and indicate MDP as a potential mediator for early inflammatory processes in the brain. It also positions microglia as an important target in the gut microbiota-brain-axis pathway through PGN signalling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acetylmuramyl-Alanyl-IsoglutamineMicrogliaPeptidoglycanSignal TransductionAnimalsMiceChemokine CCL5CytokinesMAP Kinase Signaling SystemNF-kappa B

Stichwörter der Autor:innen

CCL5Commensal bacteriaGut-microbiota-brain-axisMAPKMicrogliaMuramyl dipeptideNF-κBNod2PeptidoglycanRANTESTNF-α

Substanzen

Acetylmuramyl-Alanyl-IsoglutamineChemokine CCL5CytokinesNF-kappa BPeptidoglycan

Autor:innen und Institutionen

  • Department of Neuroscience, Karolinska Institutet, 171 77 Stockholm, Sweden. Electronic address: julia.spielbauer@ki.se.
  • Drug Design & Development Section, Translational Gerontology Branch, Intramural Research Program National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, USA.
  • Department of Clinical Neuroscience, Karolinska Institutet, Centre for Molecular Medicine, Karolinska Hospital at Solna, 171 77 Stockholm, Sweden.
  • Department of Neuroscience, Karolinska Institutet, 171 77 Stockholm, Sweden.
  • Department of Neuroscience, Karolinska Institutet, 171 77 Stockholm, Sweden. Electronic address: tobias.karlsson@ki.se.

Zitieren

APA

Spielbauer, J., Glotfelty, E. J., Sarlus, H., Harris, R. A., Diaz Heijtz, R., & Karlsson, T. E. (2024). Bacterial peptidoglycan signalling in microglia: Activation by MDP via the NF-κB/MAPK pathway. Brain, Behavior, and Immunity. https://doi.org/10.1016/j.bbi.2024.06.027

Vancouver

Spielbauer J, Glotfelty EJ, Sarlus H, Harris RA, Diaz Heijtz R, Karlsson TE. Bacterial peptidoglycan signalling in microglia: Activation by MDP via the NF-κB/MAPK pathway. Brain, Behavior, and Immunity. 2024. doi:10.1016/j.bbi.2024.06.027

BibTeX
@article{Spielbauer2024,
  author = {Spielbauer, Julia and Glotfelty, Elliot J and Sarlus, Heela and Harris, Robert A and Diaz Heijtz, Rochellys and Karlsson, Tobias E},
  title = {Bacterial peptidoglycan signalling in microglia: Activation by MDP via the NF-κB/MAPK pathway},
  journal = {Brain, Behavior, and Immunity},
  year = {2024},
  doi = {10.1016/j.bbi.2024.06.027}
}
Kostenlos starten →